Use of Abciximab During Infrainguinal Peripheral Vascular Interventions: Initial Experience

Michael Silva, W. Todd Bohannon

Research output: Contribution to journalArticle

Abstract

The use of abciximab in conjunction with infrainguinal angioplasty in 16 patients over an 18-month period in 1999 was investigated. Abciximab was given to patients thought to be at high risk for a thrombotic or embolic complication. Ten patients had high-grade stenoses or occlusions in the popliteal artery and superficial femoral artery; six patients had stenoses or occlusions below the popliteal artery. After arterial access was achieved, all patients received a bolus of heparin. A weight-based nomogram, consisting of an initial bolus followed by an overnight infusion, was used to administer the abciximab. A less than 30% residual stenosis after angioplasty was considered a technical success. Patients were monitored for complications following the procedure and platelet counts were monitored for 24 hours. Technical success occurred in 94% (15116) of the patients. No significant effect on platelet count was noted. Two minor complications occurred. The major complication was a groin hematoma in a patient who was also undergoing chronic antiplatelet therapy with aspirin and clopidogrel. Abciximab has promise as an adjunct during complex infrainguinal arterial interventions but further study is needed.

Original languageEnglish (US)
Pages (from-to)153-154
Number of pages2
JournalPerspectives in Vascular Surgery and Endovascular Therapy
Volume16
Issue number2
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Blood Vessels
Popliteal Artery
Pathologic Constriction
clopidogrel
Platelet Count
Angioplasty
Nomograms
abciximab
Groin
Femoral Artery
Hematoma
Aspirin
Heparin
Weights and Measures

Keywords

  • infrainguinal angioplasty
  • popliteal artery
  • stenosis
  • superficial femoral artery

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Use of Abciximab During Infrainguinal Peripheral Vascular Interventions : Initial Experience. / Silva, Michael; Bohannon, W. Todd.

In: Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 16, No. 2, 2004, p. 153-154.

Research output: Contribution to journalArticle

@article{16e093737bbe491283342f165409beef,
title = "Use of Abciximab During Infrainguinal Peripheral Vascular Interventions: Initial Experience",
abstract = "The use of abciximab in conjunction with infrainguinal angioplasty in 16 patients over an 18-month period in 1999 was investigated. Abciximab was given to patients thought to be at high risk for a thrombotic or embolic complication. Ten patients had high-grade stenoses or occlusions in the popliteal artery and superficial femoral artery; six patients had stenoses or occlusions below the popliteal artery. After arterial access was achieved, all patients received a bolus of heparin. A weight-based nomogram, consisting of an initial bolus followed by an overnight infusion, was used to administer the abciximab. A less than 30{\%} residual stenosis after angioplasty was considered a technical success. Patients were monitored for complications following the procedure and platelet counts were monitored for 24 hours. Technical success occurred in 94{\%} (15116) of the patients. No significant effect on platelet count was noted. Two minor complications occurred. The major complication was a groin hematoma in a patient who was also undergoing chronic antiplatelet therapy with aspirin and clopidogrel. Abciximab has promise as an adjunct during complex infrainguinal arterial interventions but further study is needed.",
keywords = "infrainguinal angioplasty, popliteal artery, stenosis, superficial femoral artery",
author = "Michael Silva and Bohannon, {W. Todd}",
year = "2004",
doi = "10.1177/153100350401600222",
language = "English (US)",
volume = "16",
pages = "153--154",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Use of Abciximab During Infrainguinal Peripheral Vascular Interventions

T2 - Initial Experience

AU - Silva, Michael

AU - Bohannon, W. Todd

PY - 2004

Y1 - 2004

N2 - The use of abciximab in conjunction with infrainguinal angioplasty in 16 patients over an 18-month period in 1999 was investigated. Abciximab was given to patients thought to be at high risk for a thrombotic or embolic complication. Ten patients had high-grade stenoses or occlusions in the popliteal artery and superficial femoral artery; six patients had stenoses or occlusions below the popliteal artery. After arterial access was achieved, all patients received a bolus of heparin. A weight-based nomogram, consisting of an initial bolus followed by an overnight infusion, was used to administer the abciximab. A less than 30% residual stenosis after angioplasty was considered a technical success. Patients were monitored for complications following the procedure and platelet counts were monitored for 24 hours. Technical success occurred in 94% (15116) of the patients. No significant effect on platelet count was noted. Two minor complications occurred. The major complication was a groin hematoma in a patient who was also undergoing chronic antiplatelet therapy with aspirin and clopidogrel. Abciximab has promise as an adjunct during complex infrainguinal arterial interventions but further study is needed.

AB - The use of abciximab in conjunction with infrainguinal angioplasty in 16 patients over an 18-month period in 1999 was investigated. Abciximab was given to patients thought to be at high risk for a thrombotic or embolic complication. Ten patients had high-grade stenoses or occlusions in the popliteal artery and superficial femoral artery; six patients had stenoses or occlusions below the popliteal artery. After arterial access was achieved, all patients received a bolus of heparin. A weight-based nomogram, consisting of an initial bolus followed by an overnight infusion, was used to administer the abciximab. A less than 30% residual stenosis after angioplasty was considered a technical success. Patients were monitored for complications following the procedure and platelet counts were monitored for 24 hours. Technical success occurred in 94% (15116) of the patients. No significant effect on platelet count was noted. Two minor complications occurred. The major complication was a groin hematoma in a patient who was also undergoing chronic antiplatelet therapy with aspirin and clopidogrel. Abciximab has promise as an adjunct during complex infrainguinal arterial interventions but further study is needed.

KW - infrainguinal angioplasty

KW - popliteal artery

KW - stenosis

KW - superficial femoral artery

UR - http://www.scopus.com/inward/record.url?scp=84990395147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990395147&partnerID=8YFLogxK

U2 - 10.1177/153100350401600222

DO - 10.1177/153100350401600222

M3 - Article

AN - SCOPUS:84990395147

VL - 16

SP - 153

EP - 154

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 2

ER -